Table 2.
Clinical outcome in HCC patients according to CLD etiology.
| Criteria | All etiologies | Viral group | Nonviral group | p value | ||
|---|---|---|---|---|---|---|
| HBV | HCV | Alcohol | Cryptogenic | |||
| Recurrence | 5/71 (7.0) | 1/10 (10.0) | 3/27 (11.1) | 1/20 (5.0) | 0/14 (0) | 0.635 |
| Event | 27/71 (38.0) | 4/10 (40.0) | 11/27 (40.7) | 5/20 (25.0) | 7/14 (50.0) | 0.509 |
| EFS (months) | 74.5 (8.5–105.2) | 41.0 (2.5–99.0) | 87.0 (39.0–120.2) | 75.5 (38.5–100.7) | 34.0 (0.0 – 109.2) | 0.470 |
Data are expressed as absolute numbers (percentage) and median (interquartile range). Number of patients with the characteristic/number for whom the information was available. HCC, hepatocellular carcinoma; CLD, chronic liver disease; HBV, hepatitis B virus; HCV, hepatitis C virus; EFS, event-free survival. The event was defined as recurrence or death from any cause since liver transplantation. Fisher's exact test.